Form 8-K - Current report:
SEC Accession No. 0001140361-25-032533
Filing Date
2025-08-25
Accepted
2025-08-25 17:19:33
Documents
12
Period of Report
2025-08-25
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K ef20054479_8k.htm   iXBRL 8-K 32359
  Complete submission text file 0001140361-25-032533.txt   161619

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ird-20250825.xsd EX-101.SCH 3859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ird-20250825_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ird-20250825_pre.xml EX-101.PRE 16041
14 EXTRACTED XBRL INSTANCE DOCUMENT ef20054479_8k_htm.xml XML 4216
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713 248-681-9815
Opus Genetics, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)